PEG-ONCAN 3750IU-5Ml INJECTION

Get a Price/Quote

MOQ : 100 Boxes

PEG-ONCAN 3750IU-5Ml INJECTION Specification

Indication
Used for Acute Lymphoblastic Leukemia (ALL)

Dosage Form
Injection

Salt Composition
Pegaspargase (3750IU)

Enzyme Types
L-Asparaginase (pegylated)

Feature
Ready-to-use, sterile, single-use vial, pegylated for improved half-life

Ingredients
Pegaspargase, excipients, sterile water

Application

Ph Level
Approximately 7.0 - 7.5

Temperature Needed For Fermentation
36C - 38C (for enzyme activity during production)

Physical Color/Texture
Clear to slightly opalescent, colorless solution

Fermentation Smell
Odorless (pharmaceutical grade)

Enzymatic Activity
3750 IU per 5ml

Storage Instructions
Store at 2C-8C. Do not freeze.

Shelf Life
24 months

Packaging Size
Single vial of 5ml

Disposal
Dispose unused product as per hazardous drug guidelines

Administration Route
Intravenous (IV), Intramuscular (IM)

Contraindications
Hypersensitivity to Pegaspargase or L-Asparaginase

Precautions
Monitor for anaphylaxis, coagulopathy, pancreatitis, and hepatotoxicity

Compatibility
Compatible with standard IV fluids for administration

Sterility
Sterile preparation

Molecular Weight
~ PEGylated molecule; L-Asparaginase MW ~100-150 kDa (approx)

Registration Status
Approved for clinical/institutional use in India

Prescription Required
Yes

Brand Name
PEG-ONCAN

Cytotoxic Category
Antineoplastic agent

Usage
Hospital/institutional use under medical supervision

PEG-ONCAN 3750IU-5Ml INJECTION Trade Information

Minimum Order Quantity
100 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About PEG-ONCAN 3750IU-5Ml INJECTION

PEG-ONCAN 3750IU-5ml Injection is an eminent antineoplastic agent expertly formulated for oncology use in India. This optimum solution, crowned by its pegylated L-Asparaginase composition, is specially designed to treat Acute Lymphoblastic Leukemia (ALL). Each sterile, single-use vial ensures optimum safety and a ready-to-use, odorless preparation. Appropriate for administration both intravenously and intramuscularly, PEG-ONCAN brings a special deal of efficacy and reliability for institutional use. Order your supply under prescription for crowning assurance in chemotherapy protocols. Store between 2C-8C for maintained activity.

Targeted Application and Suitability

PEG-ONCAN 3750IU-5ml INJECTION is specially indicated for chemotherapy regimens in oncology, particularly for treating Acute Lymphoblastic Leukemia (ALL). Its application surface is limited to hospital and institutional use, making it suitable for administration by trained medical professionals only. This product is used for cases where pegylated L-Asparaginase is required, ensuring patients receive targeted therapy as part of their ongoing leukemia treatment in controlled settings.

Certifications, Supply, and Export Readiness

PEG-ONCAN 3750IU-5ml INJECTION holds registration and approval specifically for clinical and institutional use in India. The supply ability allows for consistent transportation throughout India's hospitals as well as estimated exports to compliant markets. Each order is shipped in secure, sterile packaging - a single 5ml vial per pack - ensuring product integrity until use. Export market requirements can be met upon request, with all certifications in place for regulated institutional transactions.

FAQ's of PEG-ONCAN 3750IU-5Ml INJECTION:

Q: How should PEG-ONCAN 3750IU-5ml INJECTION be administered?

A: PEG-ONCAN is administered intravenously or intramuscularly by healthcare professionals within hospital or institutional settings, ensuring optimal safety and efficacy.

Q: What is the primary usage of PEG-ONCAN 3750IU-5ml INJECTION?

A: This injection is primarily used as part of chemotherapy for patients diagnosed with Acute Lymphoblastic Leukemia (ALL), leveraging its antineoplastic activity.

Q: When should PEG-ONCAN not be used?

A: PEG-ONCAN should not be administered in patients with hypersensitivity to Pegaspargase or L-Asparaginase. Medical history review is essential before prescribing.